Suvretta Capital Management, LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:55 pm Sale | 2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Suvretta Capital Management, LLC | 0 0.000% | -383,880 (Position Closed) | Filing |
| 2020-11-09 4:46 pm Purchase | 2020-10-30 | 13G | Soleno Therapeutics, Inc. SLNO | Suvretta Capital Management, LLC | 383,880 7.200% | 383,880 (New Position) | Filing |